Table 3.
Univariate and Multivariate Analyses for OS in EC Patients
| Prognostic Factor | Univariate Analysis | p-value | Multivariate Analysis | p-value |
|---|---|---|---|---|
| OS | OS | |||
| HR (95% CI) | HR (95% CI) | |||
| Antibiotic/Control | 2.007 (1.213–3.319) | 0.007 | 1.900 (1.140–3.167) | 0.014 |
| Gender | 1.187 (0.685–2.056) | 0.541 | - | - |
| Male/Female | ||||
| Age | 0.818 (0.478–1.399) | 0.462 | - | - |
| <60 year/≥60 year | ||||
| Primary Tumor Location | 1.147 (0.566–2.324) | 0.703 | - | - |
| Upper/Middle-lower | ||||
| Primary Tumor Length (cm) | 1.036 (0.629–1.705) | 0.890 | - | - |
| <5/≥5 | ||||
| Histology | 0.375 (0.159–0.889) | 0.026 | 0.453 (0.190–1.080) | 0.074 |
| Squamous/Non-squamous | ||||
| ECOG Performance Status | 1.157 (0.681–1.965) | 0.589 | - | - |
| 0 | ||||
| 1 or 2 | ||||
| Treatment | 0.783 (0.469–1.306) | 0.348 | - | - |
| Chemotherapy-Radiotherapy/Chemotherapy |
Abbreviations: EC, esophageal cancer; OS, overall survival; HR, hazard ratio; CI, confidence interval; ECOG, Eastern Cooperative Oncology Group.